HedgePath Pharmaceuticals Inc.

(HPPI)

By |

Profile

HedgePath Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes therapeutics for the patients with cancer. The firm's main focus is on the development of therapies for skin, lung and prostate cancers in the United States of America market. Its product portfolio consists of Itraconazole and Suba technology.

Contact Information

Website: www.hedgepathpharma.com
Email: info@cbi-biotech.com
Main Phone: +1 813 830-7489
Address: 4830 W. Kennedy Boulverad
Address 2: Suite 600
State: FL
City / Town: Tampa
Country: USA
Postal Code: 33609

Issuer Information

Exchange: OTCQB
CEO: William X. Guo
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

HedgePath Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes therapeutics for the patients with cancer. The firm's main focus is on the development of therapies for skin, lung and prostate cancers in the United States of America market. Its product portfolio consists of Itraconazole and Suba technology.

Contact Information

Website: www.hedgepathpharma.com
Email: info@cbi-biotech.com
Main Phone: +1 813 830-7489
Address: 4830 W. Kennedy Boulverad
Address 2: Suite 600
State: FL
City / Town: Tampa
Country: USA
Postal Code: 33609

Issuer Information

Exchange: OTCQB
CEO: William X. Guo
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.08 $ 0. (0.00%)
Last Price 0.08 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.08
Last Trade Volume 0 52 Wk Hi 0.38 52 Wk Low 0.0402
Market Cap 29.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 370,446,185.00 EPS (TTM) -0.01 PE Ratio N/A Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Paul D'Sylva 1,000
Last 10 Sell Shares
Paul D'Sylva 1,000